Abstract
This study aimed to investigate potential associations between menstrual cycle (MC) phases and heart rate (HR), perceived exertion (RPE), and subjective well-being in female football players. Data were collected from 11 players (aged 17–29 years) across 10 competitive matches. HR metrics, subjective well-being, and RPE were monitored in the pre-match, during-match, and post-match periods, as was the menstrual cycle in detail. Key findings revealed that during the early luteal (EL) phase, players spent significantly more time in moderate-intensity HR zones (Zone 4) in both the first (p = 0.046) and second halves (p = 0.051), while spending less time in high-intensity zones (Zone 5) during the first half (p = 0.012). Subjective measures highlighted elevated energy levels in the EL phase compared to the late luteal phase (p = 0.001), underscoring the influence of different menstrual cycle phases on well-being. However, RPE and maximum HR were predominantly shaped by external factors such as opponent strength (p < 0.001) and match outcome (p = 0.035). These results underscore the importance of exploring individual and contextual factors in understanding performance and well-being in female football players.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee for Research at Masaryk University EKV-2024-001
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
